Transplantation of patient-specific bile duct bioengineered with chemically reprogrammed and microtopographically differentiated cells
- Document Type
- Publications · Journal Article
- Registered DB
- SCIEScopus
- Journal Ranking
- JCR Q1Scopus Q2
- Journal
- Bioengineering & Translational Medicine7(1) · #e10252 · 2022
- Citation
- Web of Science 12Scopus 13
- FWCI (Scopus)
- 0.84
- JCR IF
- JCR 2021 10.684
- ISSN
- 2380-6761
Authors
- Buisson, Elina MariaFirst authorHanyang Univ, Dept Surg, Coll Med, Seoul 04763, South Korea
- Park, Suk HeePusan Natl Univ, Sch Mech Engn, Busan, South Korea
- Kim, MyounghoiHanyang Univ, Dept Surg, Coll Med, Seoul 04763, South Korea
- Kang, KyojinHanyang Univ, Dept Surg, Coll Med, Seoul 04763, South Korea
- Yoon, SangtaeHanyang Univ, Dept Surg, Coll Med, Seoul 04763, South Korea
- Lee, Ji EunKorea Inst Ind Technol, Digital Mfg Proc Grp, Siheungsi, Gyeonggi Do, South Korea
- Kim, Young WonKorea Inst Ind Technol, Digital Mfg Proc Grp, Siheungsi, Gyeonggi Do, South Korea
- Lee, Nak KyuKorea Inst Ind Technol, Digital Mfg Proc Grp, Siheungsi, Gyeonggi Do, South Korea
- Jeong, Mi AeHanyang Univ, Dept Anesthesiol & Pain Med, Coll Med, Seoul, South Korea
- Kang, Bo-KyeongHanyang Univ, Coll Med, Dept Radiol, Seoul, South Korea
- Lee, Seung BumKorea Inst Radiol & Med Sci, Natl Radiat Emergency Med Ctr, Lab Radiat Exposure & Therapeut, Seoul, South Korea
- Factor, Valentina M.NCI, Lab Mol Pharmacol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
- Seo, DaekwanPsomagen Inc, Rockville, MD USA
- Kim, HyunsungHanyang Univ, Dept Pathol, Coll Med, Seoul, South Korea
- Jeong, JaeminCorresponding authorHanyang Univ, Dept Surg, Coll Med, Seoul 04763, South Korea
- Kim, Han JoonCorresponding authorHanyang Univ, Dept Surg, Coll Med, Seoul 04763, South Korea
- Choi, DonghoCorresponding authorHanyang Univ, Dept Surg, Coll Med, Seoul 04763, South Korea
Abstract
Cholangiopathy is a diverse spectrum of chronic progressive bile duct disorders with limited treatment options and dismal outcomes. Scaffold- and stem cell-based tissue engineering technologies hold great promise for reconstructive surgery and tissue repair. Here, we report a combined application of 3D scaffold fabrication and reprogramming of patient-specific human hepatocytes to produce implantable artificial tissues that imitate the mechanical and biological properties of native bile ducts. The human chemically derived hepatic progenitor cells (hCdHs) were generated using two small molecules A83-01 and CHIR99021 and seeded inside the tubular scaffold engineered as a synergistic combination of two layers. The inner electrospun fibrous layer was made of nanoscale-macroscale polycaprolactone fibers acting to promote the hCdHs attachment and differentiation, while the outer microporous foam layer served to increase mechanical stability. The two layers of fiber and foam were fused robustly together thus creating coordinated mechanical flexibility to exclude any possible breaking during surgery. The gene expression profiling and histochemical assessment confirmed that hCdHs acquired the biliary epithelial phenotype and filled the entire surface of the fibrous matrix after 2 weeks of growth in the cholangiocyte differentiation medium in vitro. The fabricated construct replaced the macroscopic part of the common bile duct (CBD) and re-stored the bile flow in a rabbit model of acute CBD injury. Animals that received the acellular scaffolds did not survive after the replacement surgery. Thus, the artificial bile duct constructs populated with patient-specific hepatic progenitor cells could provide a scalable and compatible platform for treating bile duct diseases.
Keywords
3D printingchemically derived hepatic progenitorscholangiocyteselectrospun fiberspatient-specific bile ductREGENERATIVE MEDICINETISSUERECONSTRUCTIONNANOTOPOGRAPHYSCAFFOLD
Identifiers
- Scopus EID
- 2-s2.0-85114098697
- WoS UID
- 000692259900001



Login
Back to Publication list